Cancer Biology

1180 CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response.

1179 Fighting against Drug‐Resistant Tumors using a Dual‐Responsive Pt(IV)/Ru(II) Bimetallic Polymer.

1178 Serine restriction alters sphingolipid diversity to constrain tumour growth.

1177 Expression of the axon-guidance gene Slit2 in endothelium, induced by endothelial sensing of tumour-derived double-stranded RNA, promotes metastatic dissemination in mouse models of breast and lung cancer.

1176 The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic.

1175 B cell acute lymphoblastic leukemia cells mediate RANK-RANKL–dependent bone destruction.

1174 Interleukin-2 signals converge in a lymphoid–dendritic cell pathway that promotes anticancer immunity.

1173 The bacterial-derived metabolite inosine enhances cancer immunotherapy in mice.

1172 Ageing in humans is associated with an increase in circulating methylmalonic acid, which induces expression of SOX4 and promotes tumour progression.

1171 An effective combination immunotherapy using oncolytic viruses delivers de novo CD19 to promote CD19-CAR T cell therapy against solid tumors in mice.

1170 Lymph protects metastasizing melanoma cells from ferroptosis.

1169 An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.

1168 Combination of BET inhibitor and vinorelbine improves survival in preclinical models of brain metastases.

1167 Discovery and molecular pharmacology of non-nucleotide STING agonists that induce “closed” STING conformation and antitumor immunity are described.

1166 A cancer evaluation criterion based on T cell receptors is potentially useful for noninvasive early cancer detection.

1165 CytoPAN—Portable cellular analyses for rapid point-of-care cancer diagnosis.

1164 Phosphoprotein-based biomarkers as predictors for cancer therapy.

1163 The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma.

1162 In vivo anticancer activity of a rhodium metalloinsertor in the HCT116 xenograft tumor model.

1161 Tumor cell lysate-loaded immunostimulatory spherical nucleic acids as therapeutics for triple-negative breast cancer.

Free Images for Presentation: sunipix SUNIPIX